News
BNGO
1.170
+1.74%
0.020
Bionano Genomics announces Bionano Symposium 2026
TipRanks · 1d ago
Bionano Genomics Hosts Global Symposium Showcasing Advances in Optical Genome Mapping
Reuters · 1d ago
Bionano Genomics Hosts Global Optical Genome Mapping Symposium 2026
Reuters · 1d ago
Bionano Genomics veranstaltet internationales Symposium zur optischen Genomkartierung
Reuters · 1d ago
Weekly Report: what happened at BNGO last week (0202-0206)?
Weekly Report · 1d ago
Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping
Barchart · 1d ago
Bionano Genomics announces publication on OGM, gene editing technology
TipRanks · 6d ago
Bionano Genomics Publishes Study On Application Of Optical Genome Mapping To Trace Genomic Alterations Introduced By Different Gene Editing Technologies
Benzinga · 6d ago
Bionano Genomics Unveils Optical Genome Mapping Study for Detecting Gene Editing Alterations
Reuters · 6d ago
Bionano Genomics kündigt Studie zur Anwendung von Optical Genome Mapping bei Genomveränderungen durch Gen-Editing an
Reuters · 6d ago
Weekly Report: what happened at BNGO last week (0126-0130)?
Weekly Report · 02/02 09:00
Weekly Report: what happened at BNGO last week (0119-0123)?
Weekly Report · 01/26 09:00
Weekly Report: what happened at BNGO last week (0112-0116)?
Weekly Report · 01/19 09:00
Reiterating Buy on Bionano Genomics: Strengthening OGM Adoption and Reimbursement Tailwinds Underpin $7 Price Target
TipRanks · 01/16 18:26
Analysts Offer Insights on Healthcare Companies: Upstream Bio, Inc. (UPB) and BioNano Genomics (BNGO)
TipRanks · 01/16 18:10
Bionano Genomics reports preliminary Q4 revenue $7.8M-$8M
TipRanks · 01/12 13:17
Bionano Genomics Reports Preliminary 2025 Results and Expands OGM System Installations
Reuters · 01/12 13:16
*Bionano Genomics Sees 2025 Rev $28.4M-$28.6M >BNGO
Dow Jones · 01/12 13:05
*Bionano Genomics 4Q Rev $7.8M Vs. $8M >BNGO
Dow Jones · 01/12 13:04
BIONANO GENOMICS INC - 2025 REVENUE EXPECTED BETWEEN $28.4 MLN AND $28.6 MLN
Reuters · 01/12 13:00
More
Webull provides a variety of real-time BNGO stock news. You can receive the latest news about Bionano Genomics Inc through multiple platforms. This information may help you make smarter investment decisions.
About BNGO
Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).